Top Medical Searches

Current Medical News

Drugmakers agree on landmark vaccines deal for poor

LONDON (Reuters) – Several drug firms have agreed on a landmark deal to supply up to 200 million doses a year of cut-price pneumococcal vaccines to developing nations, according to the global immunization alliance that is overseeing the deal.

 Read more…

March 11th, 2010

Driving With Early Alzheimer’s May Be Ill-Advised

FRIDAY, March 12 — Elderly people with failing memories often keep driving, but a study of Alzheimer’s patients suggests the risk of getting lost — even on familiar streets — may be greater than once thought.Even with early dementia, there may…


 Read more…

March 11th, 2010

Medicine’s Future Could Lie in Each Patient’s Genome

THURSDAY, March 11 — Two separate scientific teams announced this week that they had successfully sequenced individual genomes to pinpoint precise genetic causes of illness — breakthroughs that open the door to a future of individualized,…


 Read more…

March 11th, 2010

Calcium may help you live longer: study

NEW YORK (Reuters Health) – Getting a bit more calcium in your diet could help you live longer, new research suggests.

 Read more…

March 11th, 2010

Retail Spices Recalled in Salmonella Scare

Some Whole Foods and Frontier brand spices have been recalled due to possible salmonella contamination of pepper included in the products. Read more…

March 11th, 2010

Don’t Get Short-Changed by Short-Term Medical Insurance

It can be an alluring alternative to COBRA, but watch out for pitfalls in the fine print. Read more…

March 11th, 2010

Heat Therapy Helps Treat U.S. Soldiers’ Infections

THURSDAY, March 11 — Heat therapy is effective for treating lesions caused by a parasitic skin infection that afflicts U.S. soldiers in Iraq and Afghanistan, a new study shows.Since U.S. operations began in those countries, more than 1,300…


 Read more…

March 11th, 2010

Glenn Close has genes mapped

CHICAGO (Reuters) – Archbishop Desmond Tutu has done it. So has genome pioneer Craig Venter.

 Read more…

March 11th, 2010

U.S. safety panel says big Vytorin study can go on

NEW YORK (Reuters) – Merck & Co on Thursday said an independent data safety monitoring board has approved continuation of a big study meant to determine whether its blockbuster Vytorin cholesterol drug prevents heart attacks and stroke.

 Read more…

March 11th, 2010

U.S. Chalks Up Victories in War on Cancer

THURSDAY, March 11 — The decrease in cancer deaths in the United States since 1990 is the result of reduced tobacco use, increased cancer screening and improvements in treatment, according to an American Cancer Society study.Researchers analyzed…


 Read more…

March 11th, 2010

Body’s Response to Foods’ Smell, Taste Could Be Diabetes Risk Factor

THURSDAY, March 11 — A mutation that affects how the body responds when a person smells or tastes food may play a role in the development of type 2 diabetes in some people, U.S. researchers report.”Our study showed there is a novel genetic…


 Read more…

March 11th, 2010

Access Pharmaceuticals Reports Significant Oral Bioavailability of Cobalamin(TM) Oral Insulin in Additional Studies

Cobalamin Seen As Broadly Applicable For Oral Delivery OfMany Large Molecule Drugs Now Administered By InjectionDALLAS, March 11 /PRNewswire-FirstCall/ — ACCESSPHARMACEUTICALS, INC. (OTC:ACCP) (BULLETIN BOARD: ACCP) announced thatit has…


 Read more…

March 11th, 2010

Occasional High Blood Pressure Risky, Too?

Occasional high blood pressure readings are often ignored as nothing to worry about, but a new study suggests this episodic high blood pressure is a strong predictor of strokes. Read more…

March 11th, 2010

U.S. children turn to inhaling to get high: study

WASHINGTON (Reuters) – More 12-year-olds in the United States admit to using potentially deadly inhalants to get high than have used marijuana, cocaine and hallucinogens combined, U.S. health officials said on Thursday.

 Read more…

March 11th, 2010

Allon’s Phase 1 trial broadens davunetide’s intranasal safety and dose range

VANCOUVER — Allon Therapeutics Inc. (TSX: NPC) announcedtoday that a Phase 1 clinical trial of its lead neuroprotectivedrug, davunetide, which began patient enrolment January 28, 2010,has been completed.  The results demonstrated that…


 Read more…

March 11th, 2010
Copyright 2008 © Drugs and Diseases. Developed by Axilosoft
Home | About Us | Privacy Policy | Contact Us